|
1
|
Dabadghao P, Roberts BJ, Wang J, Davies MJ
and Norman RJ: Glucose tolerance abnormalities in Australian women
with polycystic ovary syndrome. Med J Aust. 187:328–331.
2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li R, Zhang Q, Yang D, Li S, Lu S, Wu X,
Wei Z, Song X, Wang X, Fu S, et al: Prevalence of polycystic ovary
syndrome in women in China: A large community-based study. Hum
Reprod. 28:2562–9256. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ovalle F and Azziz R: Insulin resistance,
polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil
Steril. 77:1095–1105. 2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
DeUgarte CM, Bartolucci AA and Azziz R:
Prevalence of insulin resistance in the polycystic ovary syndrome
using the homeostasis model assessment. Fertil Steril.
83:1454–1460. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Carmina E and Lobo RA: Use of fasting
blood to assess the prevalence of insulin resistance in women with
polycystic ovary syndrome. Fertil Steril. 82:661–665.
2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Moran LJ, Pasquali R, Teede HJ, Hoeger KM
and Norman RJ: Treatment of obesity in polycystic ovary syndrome: A
position statement of the androgen excess and polycystic ovary
syndrome society. Fertil Steril. 92:1966–1982. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Greenwood EA and Huddleston HG: Insulin
resistance in polycystic ovary syndrome: Concept versus cutoff.
Fertil Steril. 112:827–828. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zeng X, Xie YJ, Liu YT, Long SL and Mo ZC:
Polycystic ovarian syndrome: Correlation between hyperandrogenism,
insulin resistance and obesity. Clin Chim Acta. 502:214–221.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xiao XU and Xue-Lian LI: The role of
androgens in the pathogenesis and treatment of female reproductive
endocrine diseases. J Int Obstet Gynecol. 46:229–232. 2019.
|
|
10
|
Patlolla S, Vaikkakara S, Sachan A,
Venkatanarasu A, Bachimanchi B, Bitla A, Settipalli S, Pathiputturu
S, Sugali RN and Chiri S: Heterogenous origins of hyperandrogenism
in the polycystic ovary syndrome in relation to body mass index and
insulin resistance. Gynecol Endocrinol. 34:238–242. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Naver KV, Grinsted J, Larsen SO, Hedley
PL, Jørgensen FS, Christiansen M and Nilas L: Increased risk of
preterm delivery and pre-eclampsia in women with polycystic ovary
syndrome and hyperandrogenaemia. BJOG. 121:575–581. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Elenis E, Desroziers E, Persson S,
Sundström Poromaa I and Campbell RE: Early initiation of
anti-androgen treatment is associated with increased probability of
spontaneous conception leading to childbirth in women with
polycystic ovary syndrome: A population-based multiregistry cohort
study in Sweden. Hum Reprod. 36:1427–1435. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chang EM, Han JE, Seok HH, Lee DR, Yoon TK
and Lee WS: Insulin resistance does not affect early embryo
development but lowers implantation rate in in vitro maturation-in
vitro fertilization-embryo transfer cycle. Clin Endocrinol.
79:93–99. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tian L, Shen H, Lu Q, Norman RJ and Wang
J: Insulin resistance increases the risk of spontaneous abortion
after assisted reproduction technology treatment. J Clin Endocrinol
Metab. 92:1430–1433. 2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Khattab S, Mohsen IA, Foutouh IA, Ramadan
A, Moaz M and Al-Inany H: Metformin reduces abortion in pregnant
women with polycystic ovary syndrome. Gynecol Endocrinol.
22:680–684. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang K, Liao X, Dong X and Zhang H:
Effect of overweight/obesity on IVF-ET outcomes in Chinese patients
with polycystic ovary syndrome. Int J Clin Exp Med. 7:5872–5876.
2014.PubMed/NCBI
|
|
17
|
Veleva Z, Tiitinen A, Vilska S,
Hydén-Granskog C, Tomás C, Martikainen H and Tapanainen JS: High
and low BMI increase the risk of miscarriage after IVF/ICSI and
FET. Hum Reprod. 23:878–884. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fedorcsák P, Storeng R, Dale PO, Tanbo T
and Abyholm T: Obesity is a risk factor for early pregnancy loss
after IVF or ICSI. Acta Obstet Gynecol Scand. 79:43–48.
2000.PubMed/NCBI
|
|
19
|
Bu Z, Dai W, Guo Y, Su Y, Zhai J and Sun
Y: Overweight and obesity adversely affect outcomes of assisted
reproductive technologies in polycystic ovary syndrome patients.
Int J Clin Exp Med. 6:991–995. 2013.PubMed/NCBI
|
|
20
|
Patel SS and Carr BR: Oocyte quality in
adult polycystic ovary syndrome. Semin Reprod Med. 26:196–203.
2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jungheim ES, Schon SB, Schulte MB,
DeUgarte DA, Fowler SA and Tuuli MG: IVF outcomes in obese donor
oocyte recipients: A systematic review and meta-analysis. Hum
Reprod. 28:2720–2727. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wattanakumtornkul S, Damario MA, Stevens
HS, Thornhill AR and Tummon IS: Body mass index and uterine
receptivity in the oocyte donation model. Fertil Steril.
80:336–340. 2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bellver J, Rossal LP, Bosch E, Zúñiga A,
Corona JT, Meléndez F, Gómez E, Simón C, Remohí J and Pellicer A:
Obesity and the risk of spontaneous abortion after oocyte donation.
Fertil Steril. 79:1136–1140. 2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Piltonen TT: Polycystic ovary syndrome:
Endometrial markers. Best Pract Res Clin Obstet Gynaecol. 37:66–79.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Takemura Y, Osuga Y, Yamauchi T, Kobayashi
M, Harada M, Hirata T, Morimoto C, Hirota Y, Yoshino O, Koga K, et
al: Expression of adiponectin receptors and its possible
implication in the human endometrium. Endocrinology. 147:3203–3210.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang Y, Xie X and Zhu W: Serum adiponectin
and resistin levels in patients with polycystic ovarian syndrome
and their clinical implications. J Huazhong Univ Sci Technolog Med
Sci. 30:638–642. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Barbe A, Bongrani A, Mellouk N, Estienne
A, Kurowska P, Grandhaye J, Elfassy Y, Levy R, Rak A, Froment P and
Dupont J: Mechanisms of adiponectin action in fertility: An
overview from gametogenesis to gestation in humans and animal
models in normal and pathological conditions. Int J Mol Sci.
20(1526)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fisher FM, Trujillo ME, Hanif W, Barnett
AH, McTernan PG, Scherer PE and Kumar S: Serum high molecular
weight complex of adiponectin correlates better with glucose
tolerance than total serum adiponectin in Indo-Asian males.
Diabetologia. 48:1084–1087. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yamauchi T, Iwabu M, Okada-Iwabu M and
Kadowaki T: Adiponectin receptors: A review of their structure,
function and how they work. Best Pract Res Clin Endocrinol Metab.
28:15–23. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rosenbaum D, Haber RS and Dunaif A:
Insulin resistance in polycystic ovary syndrome: Decreased
expression of GLUT-4 glucose transporters in adipocytes. Am J
Physiol. 264:E197–E202. 1993.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group. Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome. Fertil Steril. 81:19–25. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chang WY, Knochenhauer ES, Bartolucci AA
and Azziz R: Phenotypic spectrum of polycystic ovary syndrome:
Clinical and biochemical characterization of the three major
clinical subgroups. Fertil Steril. 83:1717–1723. 2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Soonthornpun S, Setasuban W, Thamprasit A,
Chayanunnukul W, Rattarasarn C and Geater A: Novel insulin
sensitivity index derived from oral glucose tolerance test. J Clin
Endocrinol Metab. 88:1019–1023. 2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Salley KE, Wickham EP, Cheang KI, Essah
PA, Karjane NW and Nestler JE: Glucose intolerance in polycystic
ovary syndrome-a position statement of the androgen excess society.
J Clin Endocrinol Metab. 92:4546–4556. 2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Finucane MM, Stevens GA, Cowan MJ, Danaei
G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN,
et al: National, regional, and global trends in body-mass index
since 1980: Systematic analysis of health examination surveys and
epidemiological studies with 960 country-years and 9.1 million
participants. Lancet. 377:557–567. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Noyes RW, Hertig AT and Rock J: Reprint
of: Dating the endometrial biopsy. Fertil Steril. 112 (4 Suppl
1):e93–e115. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Quezada S, Avellaira C, Johnson MC, Gabler
F, Fuentes A and Vega M: Evaluation of steroid receptors,
coregulators, and molecules associated with uterine receptivity in
secretory endometria from untreated women with polycystic ovary
syndrome. Fertil Steril. 85:1017–1026. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Livak KJ and Schmittgen TDL: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Matteo M, Serviddio G, Massenzio F,
Scillitani G, Castellana L, Picca G, Sanguedolce F, Cignarelli M,
Altomare E, Bufo P, et al: Reduced percentage of natural killer
cells associated with impaired cytokine network in the secretory
endometrium of infertile women with polycystic ovary syndrome.
Fertil Steril. 94:2222–2227.e1-e3. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sinclair JC and Haynes RB: Selecting
participants that raise a clinical trial's population attributable
fraction can increase the treatment effect within the trial and
reduce the required sample size. J Clin Epidemiol. 64:893–902.
2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Garcia V, Oróstica L, Poblete C, Rosas C,
Astorga I, Romero C and Vega M: Endometria from obese PCOS women
with hyperinsulinemia exhibit altered adiponectin signaling. Horm
Metab Res. 47:901–909. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wickham ER III, Cheang KI, Clore JN,
Baillargeon JP and Nestler JE: Total and high-molecular weight
adiponectin in women with the polycystic ovary syndrome.
Metabolism. 60:366–372. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
O'Connor A, Phelan N, Tun TK, Boran G,
Gibney J and Roche HM: High-molecular-weight adiponectin is
selectively reduced in women with polycystic ovary syndrome
independent of body mass index and severity of insulin resistance.
J Clin Endocrinol Metab. 95:1378–1385. 2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Panidis D, Kourtis A, Farmakiotis D,
Mouslech T, Rousso D and Koliakos G: Serum adiponectin levels in
women with polycystic ovary syndrome. Hum Reprod. 18:1790–1796.
2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Xu A, Chan KW, Hoo RL, Wang Y, Tan KC,
Zhang J, Chen B, Lam MC, Tse C, Cooper GJ and Lam KS: Testosterone
selectively reduces the high molecular weight form of adiponectin
by inhibiting its secretion from adipocytes. J Biol Chem.
280:18073–18080. 2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lecke SB, Mattei F, Morsch DM and Spritzer
PM: Abdominal subcutaneous fat gene expression and circulating
levels of leptin and adiponectin in polycystic ovary syndrome.
Fertil Steril. 95:2044–2049. 2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Barber TM, Hazell M, Christodoulides C,
Golding SJ, Alvey C, Burling K, Vidal-Puig A, Groome NP, Wass JA,
Franks S and McCarthy MI: Serum levels of retinol-binding protein 4
and adiponectin in women with polycystic ovary syndrome:
Associations with visceral fat but no evidence for fat
mass-independent effects on pathogenesis in this condition. J Clin
Endocrinol Metab. 93:2859–2865. 2008.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Snijders MP, de Goeij AF, Debets-Te Baerts
MJ, Rousch MJ, Koudstaal J and Bosman FT: Immunocytochemical
analysis of oestrogen receptors and progesterone receptors in the
human uterus throughout the menstrual cycle and after the
menopause. J Reprod Fertil. 94:363–371. 1992.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gellersen B and Brosens JJ: Cyclic
decidualization of the human endometrium in reproductive health and
failure. Endocr Rev. 35:851–905. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Weyer C, Tataranni PA, Bogardus C and
Pratley RE: Insulin resistance and insulin secretory dysfunction
are independent predictors of worsening of glucose tolerance during
each stage of type 2 diabetes development. Diabetes Care. 24:89–94.
2001.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Benkhalifa M, Madkour A, Louanjli N,
Bouamoud N, Saadani B, Kaarouch I, Chahine H, Sefrioui O, Merviel P
and Copin H: From global proteome profiling to single targeted
molecules of follicular fluid and oocyte: Contribution to embryo
development and IVF outcome. Expert Rev Proteomics. 12:407–423.
2015.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lessey BA, Palomino WA, Apparao KB, Young
SL and Lininger RA: Estrogen receptor-alpha (ER-alpha) and defects
in uterine receptivity in women. Reprod Biol Endocrinol. 4 (Suppl
1)(S9)2006.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Young SL and Lessey BA: Progesterone
function in human endometrium: Clinical perspectives. Semin Reprod
Med. 28:5–16. 2010.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gnainsky Y, Granot I, Aldo PB, Barash A,
Or Y, Schechtman E, Mor G and Dekel N: Local injury of the
endometrium induces an inflammatory response that promotes
successful implantation. Fertil Steril. 94:2030–2036.
2010.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Gregory CW, Wilson EM, Apparao KB,
Lininger RA, Meyer WR, Kowalik A, Fritz MA and Lessey BA: Steroid
receptor coactivator expression throughout the menstrual cycle in
normal and abnormal endometrium. J Clin Endocrinol Metab.
87:2960–2966. 2002.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Margarit L, Taylor A, Roberts MH, Hopkins
L, Davies C, Brenton AG, Conlan RS, Bunkheila A, Joels L, White JO
and Gonzalez D: MUC1 as a discriminator between endometrium from
fertile and infertile patients with PCOS and endometriosis. J Clin
Endocrinol Metab. 95:5320–5329. 2010.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Cermik D, Selam B and Taylor HS:
Regulation of HOXA-10 expression by testosterone in vitro and in
the endometrium of patients with polycystic ovary syndrome. J Clin
Endocrinol Metab. 88:238–243. 2003.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Piltonen TT, Chen JC, Khatun M,
Kangasniemi M, Liakka A, Spitzer T, Tran N, Huddleston H, Irwin JC
and Giudice LC: Endometrial stromal fibroblasts from women with
polycystic ovary syndrome have impaired progesterone-mediated
decidualization, aberrant cytokine profiles and promote enhanced
immune cell migration in vitro. Hum Reprod. 30:1203–1215.
2015.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Gamundi-Segura S, Serna J, Oehninger S,
Horcajadas JA and Arbones-Mainar JM: Effects of adipocyte-secreted
factors on decidualized endometrial cells: Modulation of
endometrial receptivity in vitro. J Physiol Biochem. 71:537–546.
2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Palin MF, Bordignon VV and Murphy BD:
Adiponectin and the control of female reproductive functions. Vitam
Horm. 90:239–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Yoshino O, Osuga Y, Hirota Y, Koga K,
Hirata T, Yano T, Ayabe T, Tsutsumi O and Taketani Y: Endometrial
stromal cells undergoing decidualization down-regulate their
properties to produce proinflammatory cytokines in response to
interleukin-1 beta via reduced p38 mitogen-activated protein kinase
phosphorylation. J Clin Endocrinol Metab. 88:2236–2241.
2003.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Comstock IA, Diaz-Gimeno P, Cabanillas S,
Bellver J, Sebastian-Leon P, Shah M, Schutt A, Valdes CT,
Ruiz-Alonso M, Valbuena D, et al: Does an increased body mass index
affect endometrial gene expression patterns in infertile patients?
A functional genomics analysis. Fertil Steril. 107:740–748.e2.
2017.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Tierney EP, Tulac S, Huang ST and Giudice
LC: Activation of the protein kinase A pathway in human endometrial
stromal cells reveals sequential categorical gene regulation.
Physiol Genomics. 16:47–66. 2003.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Gellersen B, Brosens IA and Brosens JJ:
Decidualization of the human endometrium: Mechanisms, functions,
and clinical perspectives. Semin Reprod Med. 25:445–453.
2007.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Giudice LC: Endometrium in PCOS:
Implantation and predisposition to endocrine CA. Best Pract Res
Clin Endocrinol Metab. 20:235–244. 2006.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Laird SM, Tuckerman EM, Cork BA, Linjawi
S, Blakemore AI and Li TC: A review of immune cells and molecules
in women with recurrent miscarriage. Hum Reprod Update. 9:163–174.
2003.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Piltonen TT, Chen J, Erikson DW, Spitzer
TL, Barragan F, Rabban JT, Huddleston H, Irwin JC and Giudice LC:
Mesenchymal stem/progenitors and other endometrial cell types from
women with polycystic ovary syndrome (PCOS) display inflammatory
and oncogenic potential. J Clin Endocrinol Metab. 98:3765–3775.
2013.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Habiba MA, Bell SC and Al-Azzawi F: The
effect of hormone replacement therapy on the immunoreactive
concentrations in the endometrium of oestrogen and progesterone
receptor, heat shock protein 27, and human beta-lactoglobulin. Hum
Reprod. 15:36–42. 2000.PubMed/NCBI View Article : Google Scholar
|
